Noom Med vs Oak Longevity: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Oak Longevity beats Noom Med overall, scoring 7.5/10 vs 7.4/10. Noom Med is more affordable at $69/mo vs $130/mo. Choose Noom Med for users who want a tiered entry into glp-1 care — from $69 bra. Choose Oak Longevity for budget-conscious users who want one of the cheapest compound.
A side-by-side comparison of Noom Med and Oak Longevity covering pricing, scores, medication types, insurance, and more to help you decide.
Noom Med
#25 of 42Noom restructured Noom Med in 2026 into 3 tiers: $69/mo branded telehealth (med out-of-pocket), $99-149/mo Microdose GLP-1Rx (low-dose + biomarker monitoring), and the Full GLP-1Rx program ($149 intro → $349/mo on 12-week subscription). Coaching app included at every tier.
Visit Noom MedOak Longevity
#23 of 42Telehealth platform offering compounded semaglutide and tirzepatide at the lower end of market pricing, alongside an oral Wegovy option, brand-name FDA-approved GLP-1s, and a longevity stack (NAD+, Glutathione, Sermorelin, Tesamorelin). Distinctive non-subscription billing — patients pay each month manually rather than auto-renew.
Visit Oak Longevity| Feature | Noom Med | Oak Longevity |
|---|---|---|
| Our Score | 7.4/10 | 7.5/10 |
| Starting Price | $69/mo | $130/mo |
| Medication Type | Both | Both |
| Insurance Accepted | Yes | No |
| Best For | Users who want a tiered entry into GLP-1 care — from $69 branded telehealth to a full $349/mo medication + coaching program, with a new Microdose option at $99-149 | Budget-conscious users who want one of the cheapest compounded GLP-1 entries plus a no-subscription billing model and a longevity-stack add-on (NAD+, Sermorelin) |
| Ranking | #25 | #23 |
Pros & Cons Compared
Noom Med
Pros
- +Tiered 2026 entry — $69/mo branded telehealth tier lets users start with just medication access and the coaching app
- +New Microdose GLP-1Rx program ($99-149/mo) — low-dose GLP-1 + biomarker monitoring for sensitive users
- +Insurance accepted for qualifying plans — can significantly reduce out-of-pocket costs on brand-name meds
- +Industry-leading behavioral coaching app with years of psychology-based weight loss methodology
Cons
- −Tiered pricing creates confusion — $69, $99-149, or $149-349 depending on tier
- −Full GLP-1Rx program requires 12-week subscription ($149 intro rate applies only for the first few weeks)
- −Medication costs on the $69 tier are out-of-pocket — the low tier price is just the platform
- −App coaching still requires real engagement — skip-prone users waste the behavioral value
Oak Longevity
Pros
- +$130/mo for compounded semaglutide is among the cheapest entries on the market — Sprout Health ($99) and Sesame Care ($99) are lower, but Oak undercuts most mid-tier platforms
- +Compounded tirzepatide at $199/mo is competitively priced for a GLP-1+GIP dual agonist
- +No-subscription model — patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
- +Broadest medication mix on the platform: compounded sema + tirz, oral Wegovy, brand Wegovy/Ozempic/Zepbound/Mounjaro, plus longevity peptides (NAD+, Glutathione, Sermorelin, Tesamorelin)
- +Money-back guarantee if not approved by physician — useful safety net for borderline-eligibility patients
- +Free shipping and free health coaching included in every program
Cons
- −Brand-name pricing ($1,200-$1,500/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo, LillyDirect Zepbound $299/mo. Never buy brand-name through Oak
- −No published lab panels, no specialty (obesity medicine) physicians disclosed — clinical depth is shallow
- −'Up to 50% cheaper than competitors' marketing claim is unverified and inconsistent — depends on which competitor and which medication tier
- −'Longevity' framing pushes users toward add-on products (NAD+, Sermorelin, Tesamorelin) that have limited clinical evidence for weight loss specifically
- −Newer brand without disclosed company history, founding date, or executive team on landing pages
- −Three-month plans are billed upfront — pricing transparency is good, but commit-up-front is a friction point for users testing the platform
Our Verdict
Oak Longevity edges out Noom Med with a score of 7.5/10 vs 7.4/10. If budget is your priority, Noom Med starts at $69/mo compared to Oak Longevity's $130/mo. Noom Med accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Noom Med if you want: users who want a tiered entry into glp-1 care — from $69 branded telehealth to a full $349/mo medication + coaching program, with a new microdose option at $99-149. Choose Oak Longevity if you want: budget-conscious users who want one of the cheapest compounded glp-1 entries plus a no-subscription billing model and a longevity-stack add-on (nad+, sermorelin).